Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein

Journal of Immunology

Volumn 168, Issue 11, 2002, Pages 5792-5797

  Szalai, Alexander J ^a   Nataf, Serge ^a   Hu, Xian Zhen ^a   Barnum, Scott R ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD11B ANTIGEN; CD3 ANTIGEN; CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; INFLAMMATION; INFLAMMATORY CELL; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0036604274     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.11.5792     Document Type: Article

References (49)

1. Serological reactions in pneumonia with non-protein somatic fraction of pneumococcus
2. The antimicrobial activity of C-reactive protein
3. A role for C-reactive protein in the complement-mediated stimulation of human neutrophils by type 27 Streptococcus pneumoniae
4. Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component
5. Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae
6. C-reactive protein: Structural biology and host-defense function
7. Regulation of complement activation by C-reactive protein
8. C-reactive protein binds to FcγRI in transfected COS cells
9. The major receptor for C-reactive protein on leukocytes is Fcγ receptor II
10. C-reactive protein binding to murine leukocytes requires Fcγ receptors
11. C-reactive protein binding to FcγRIIa on human monocytes and neutrophils is allele-specific
12. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: Implications for systemic autoimmunity
13. New insights into the biology of the acute phase response
14. Acute-phase proteins and other systemic responses to inflammation
15. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
16. Isolation of mouse C-reactive protein from liver and serum
17. Inducible and tissuespecific expression of human C-reactive protein in transgenic mice
18. Myelin oligodendrocyte glycoprotein: A novel candidate autoantigen in multiple sclerosis
19. Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice
20. Demonstration of calcium-induced conformational change(s) in C-reactive protein by using monoclonal antibodies
21. Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis
22. Cutting edge commentary: Chemokine regulation of experimental autoimmune encephalomyelitis: Temporal and spatial expression patterns govern disease pathogenesis
23. Localization of C-reactive protein in inflammatory lesions of experimental allergic encephalomyelitis
24. Attenuation of experimental autoimmune demyelination in complement deficient mice
25. Onset of experimental allergic encephalomyelitis is delayed in transgenic mice expressing human C-reactive protein
26. Epidemiology of multiple sclerosis: A critical overview
27. Macrophage inflammatory proteins 1 and 2: An overview
28. Macrophage inflammatory protein I modulates macrophage function
29. Tumor necrosis factor-α and interferon-γ synergistically activate the RANTES promoter through nuclear factor κB and interferon regulatory factor 1 (IRF-1) transcription factors
30. Interleukin 10 induces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
31. The role of IL-10 in crossregulation of Th1 and Th2 responses
32. TNF accelerates the onset but does not alter the incidence and severity of myelin basic proteininduced experimental autoimmune encephalomyelitis
33. Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient mice
34. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis
35. Effects of C-reactive protein of lymphocyte functions. III. Inhibition of antigen-induced lymphocyte stimulation and lymphokine production
36. Effect of human C-reactive protein on chemokine and chemotactic factorinduced neutrophil chemotaxis and signaling
37. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerotic drugs
38. C-reactive protein inhibits chemotactic peptide-induced p38 mitogen-activated protein kinase activity and human neutrophil movement
39. Inhibition of C5a desArg-induced neutrophil alveolitis in transgenic mice expressing C-reactive protein
40. Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis
41. Modulation of human neutrophil function by C-reactive protein
42. Prevention of in vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein
43. C-reactive protein: A physiological activator of interleukin 6 receptor shedding
44. Binding of C-reactive protein to antigen-induced but not mitogen-induced T lymphoblasts
45. Lymphocytes binding C-reactive protein and streptococcal membranes in acute rheumatic fever
46. Deletion of Fc receptor IIb renders H-2b mice susceptible to collagen-induced arthritis
47. Induction and suppression of collagen-induced arthritis is dependent on distinct Fc receptors
48. B cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization
49. Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis